![[fetch_key]](https://stocktradeupdates.com/wp-content/uploads/new_logos/MEDICO.png)
Share the post "MEDICO REMEDIES ‘s Q3 2024-25 Latest News: Revenue Grows by 32.64% YoY"
Highlights
🔹 The presented financial data is Standalone to provide a comprehensive overview of the company performance. 🔹 Sales over the Year and quarter: The company experienced a substantial growth of 32.64 % in the past year, substantial increase in net sales/revenue by 0.36 %. 🔹 Income over the Year and quarter: There has been either a marginal increase or a decline in other income over the past year which is 421.98 %. Marginal increase in other income during this quarter, up by 110.18%. 🔹 Profit over the Year and quarter: Significant improvement in profitability for MEDICO REMEDIES LIMITED. Notable increase of 81.31 % in net profit Year to Year, MEDICO REMEDIES LIMITED’s profitability increased by 68.6 % in this quarter. 🔹 EPS over the Year and quarter: EPS increased by 88.24 % Year to Year. EPS increased by 68.42 % in previous quarter. Positive impact on shareholders.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 29.772 Cr | Rs. 39.349 Cr | Rs. 39.49 Cr | + 0.36 % | + 32.64 % |
| Expenses | Rs. 27.04 Cr | Rs. 36.94 Cr | Rs. 36.37 Cr | -1.54 % | + 34.5 % |
| Operating Profit | Rs. 2.73 Cr | Rs. 2.41 Cr | Rs. 3.12 Cr | + 29.46 % | + 14.29 % |
| OPM % | 9.17 % | 6.12 % | 7.9 % | + 1.78 % | -1.27 % |
| Other Income | Rs. 0.273 Cr | Rs. 0.678 Cr | Rs. 1.425 Cr | + 110.18 % | + 421.98 % |
| Interest | Rs. 0.22 Cr | Rs. 0.21 Cr | Rs. 0.28 Cr | + 33.33 % | + 27.27 % |
| Depreciation | Rs. 0.72 Cr | Rs. 0.75 Cr | Rs. 0.76 Cr | + 1.33 % | + 5.56 % |
| Profit before tax | Rs. 2.06 Cr | Rs. 2.13 Cr | Rs. 3.51 Cr | + 64.79 % | + 70.39 % |
| Tax % | 29.96 % | 27.11 % | 25.1 % | -2.01 % | -4.86 % |
| Net Profit | Rs. 1.45 Cr | Rs. 1.55 Cr | Rs. 2.62 Cr | + 69.03 % | + 80.69 % |
| EPS in Rs | Rs. 0.17 | Rs. 0.19 | Rs. 0.32 | + 68.42 % | + 88.24 % |
Today, we’re looking at MEDICO REMEDIES LIMITED’s financial performance for the Q3(Dec 2024-25).Starting with the top line, the company reported a robust year-over-year sales growth of 32.64 %. However, it did see a marginal increase of 0.36 % from the previous quarter. Expenses decreased slightly by -1.54 % quarter-on-quarter, aligning with the annual rise of 34.5 %. Operating profit, while up 14.29 % compared to last year, faced a quarter-on-quarter increase of 29.46 %, signaling a short-term expansion in margins.
The Operating Profit Margin (OPM) % contradicts this narrative, showing weakness on an annual basis with a decrease of -1.27 %, but an expansion of 1.78 % sequentially. Other income rose by 110.18 % compared to the last quarter, despite an annual growth of 421.98 %. Interest expenses surged remarkably by 33.33 % from the previous quarter, yet the year-over-year increase remains at a moderate 27.27 %. Depreciation costs climbed by 1.33 % quarter-on-quarter, whereas on an annual scale, they saw an increase of 5.56 %. Profit before tax grew annually by 70.39 % but saw an increase from the preceding quarter by 64.79 %.
Tax expenses as a percentage of profits decreased slightly by -4.86 % compared to last year, with a more notable quarter-on-quarter decrease of -2.01 %. Net profit rose by 80.69 % year-on-year but experienced a 69.03 % expansion from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 88.24 % but a quarterly rise of 68.42 %. In summary, MEDICO REMEDIES LIMITED’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 29.772 Cr | Rs. 39.349 Cr | Rs. 39.49 Cr | + 0.36 % | + 32.64 % |
| Expenses | Rs. 27.04 Cr | Rs. 36.94 Cr | Rs. 36.37 Cr | -1.54 % | + 34.5 % |
| Operating Profit | Rs. 2.73 Cr | Rs. 2.41 Cr | Rs. 3.12 Cr | + 29.46 % | + 14.29 % |
| Net Profit | Rs. 1.45 Cr | Rs. 1.55 Cr | Rs. 2.62 Cr | + 69.03 % | + 80.69 % |
| EPS in Rs | Rs. 0.17 | Rs. 0.19 | Rs. 0.32 | + 68.42 % | + 88.24 % |
In reviewing MEDICO REMEDIES LIMITED’s 2024-25(Q3) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 32.64 % year-on-year growth, however, there was a minor increase of 0.36 % from the previous quarter. Expenses rose by 34.5 % compared to the previous year, with a decrease of -1.54 % quarter-on-quarter. Operating Profit surged by 14.29 % annually, and saw a 29.46 % increase from the last quarter.
Net Profit showed yearly increase of 80.69 %, and experienced a 69.03 % increase from the previous quarter. Earnings Per Share (EPS) rose by 88.24 % annually, however rose by 68.42 % compared to the last quarter. In essence, while MEDICO REMEDIES LIMITED exhibits strong annual growth indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.
